Indian Medicine Sales Rise 12% to ₹70,180 Crore in September Quarter
Published
Sales of medicines in India grew by 12 percent during the September quarter, reaching ₹70,180 crore, according to a report from eHealth Magazine. The figures show that demand for medicines remains strong across the country, and the growth reflects steady activity in the healthcare market.
The increase in sales suggests that more people are buying medicines, both for common illnesses and for long-term health needs. Pharmaceutical companies and retail pharmacies have benefited from this trend. Experts often watch quarterly medicine sales closely because they give an early picture of how the health sector is performing.
The report does not give a detailed breakdown of the reasons behind the rise. However, the strong figures indicate that the healthcare sector continues to play an important role in the Indian economy. Readers who want more details are advised to read the full report from the original source.
In summary, medicine sales in India grew by 12 percent in the September quarter to ₹70,180 crore. This growth shows continued demand for medicines and a healthy performance in the country's pharmaceutical market.
Sources: eHealth Magazine
More India news
- Cheaper Batteries Make Solar and Wind the Lowest-Cost Power Source in India, Says BNEF
- Why Money Flowing Out of India Is Drawing Attention
- Qualcomm Layoffs: What Severance Will Former Employees in India Receive?
- Suriya's Cop Comedy 'Scene' Earns Rs 111 Crore in Five Days at the Box Office
- Ajay Devgn's Drishyam 3: The Conclusion Passes Rs 588 Crore Worldwide After 40 Days
- Ramayana: Part 1 Continues Strong Box Office Run with Rs 440 Crore Collection
- Government Uses Online Marketplace to Buy Farm and Allied Sector Goods
- World Bank Estimates Extreme Poverty in India at 2.6 Per Cent, Sparking Debate